Global HbA1c Testing Market Research Report—Forecast till 2025

Global HbA1c Testing Market: Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market analysis

In general, diabetes has become one of the most prevalent epidemics across the world, and among the three types of diabetes, type 2 diabetes is the most common. Agreeing to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes is anticipated to be the seventh prominent cause of death by 2030. Moreover, according to data published by the International Diabetes Federation in 2017, the prevalence of diabetes in Brazil was 8.7% among adults and reported 12,465,800 cases of diabetes in 2017. HbA1c Testing Market is anticipated to enroll a CAGR of 12.24% to reach USD 1,992.44 Million by 2025. Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months. These ever-increasing occurrences push for various testing methods such as HbA1c testing in patients for diagnosis. Therefore, this factor is supporting the market growth of the global HbA1c testing market.

Market segmentation

The global HbA1c testing market has been segmented by product, technology, and end user respectively. The market, based on product, has been split into reagents and kits and instruments. The market, based on instruments, has been further segmented into a bench-top device and handheld device. Based on technology, the HbA1c testing market has been separated into ion-exchange HPLC, enzymatic assay, TINIA, and others. The global HbA1c testing market, based on end user, has been divided into hospitals and clinics, diagnostic laboratories, and others.

Regional analysis

Geographically the Global HbA1c testing market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The European market for HbA1c testing is expected to be the second largest during the review period. Their growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as relationships and agreements by the prominent players is expected to boost the growth of the regional market. Asia-Pacific is estimated to be the fastest-growing market owing to the developing healthcare infrastructure and ever-increasing per capita disposable incomes. The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare. The growing awareness regarding healthcare and the availability of new advanced treatment options are factors expected to drive the growth of the market in the region. The Global HbA1c Testing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is likely to dominate the global HbA1c testing market. This can be attributed to growing activities such as research, recognition campaigns, and joint ventures by public and private organizations in the US and Canada.

Major players
The proposed spectators in the Global HbA1c testing market are Detonator manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global HbA1c testing market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global HbA1c testing market are companies like Agappe Diagnostics Ltd (India), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), PTS Diagnostics (US), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), Tosoh India Pvt. Ltd. (India) and DiaSys Diagnostic Systems GmbH (Germany).


1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 14

1.2 MARKET ATTRACTIVENESS ANALYSIS 15

1.3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT 16

1.4 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY 17

1.5 GLOBAL HBA1C TESTING MARKET, BY END USER 18

2 Market Introduction
2.1 DEFINITION 19

2.2 SCOPE OF THE STUDY 19

2.3 RESEARCH OBJECTIVE 19

2.4 MARKET STRUCTURE 20

2.5 ASSUMPTIONS & LIMITATIONS 20

3 Research Methodology
3.1 DATA MINING 21

3.2 SECONDARY RESEARCH 22

3.3 PRIMARY RESEARCH 23

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 25

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26

3.6.1 BOTTOM-UP APPROACH 27

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS
4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 RISING PREVALENCE OF DIABETES 30

4.2.2 INCREASING INITIATIVES BY KEY PLAYERS 30

4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 30

4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 30

4.3 RESTRAINTS 32

4.3.1 LIMITED INDICATIONS OF HBA1C TESTS 32

4.3.2 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 32

4.4 OPPORTUNITIES 33

4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES 33

4.4.2 INCORPORATION OF VARIOUS TECHNOLOGIES IN HBA1C TESTING INSTRUMENTS 33

5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34

5.1.1 THREAT OF NEW ENTRANTS 34

5.1.2 BARGAINING POWER OF SUPPLIERS 35

5.1.3 THREAT OF SUBSTITUTES 35

5.1.4 BARGAINING POWER OF BUYERS 35

5.1.5 INTENSITY OF RIVALRY 35

5.2 VALUE CHAIN ANALYSIS 36

5.2.1 R&D AND DESIGNING 37

5.2.2 MANUFACTURING 37

5.2.3 DISTRIBUTION 37

5.2.4 MARKETING & SALES 37

5.2.5 POST-SALES MONITORING 37

6 GLOBAL HBA1C TESTING MARKET, BY PRODUCT
6.1 OVERVIEW 38

6.2 REAGENTS & KITS 39

6.3 INSTRUMENTS 40

6.3.1 BENCH-TOP DEVICE 41

6.3.2 HANDHELD DEVICE 42

7 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY
7.1 OVERVIEW 43

7.2 ION-EXCHANGE HPLC 44

7.3 ENZYMATIC ASSAY 45

7.4 TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA) 46

7.5 OTHERS 46

8 GLOBAL HBA1C TESTING MARKET, BY END USER
8.1 OVERVIEW 47

8.2 HOSPITALS AND CLINICS 48

8.3 DIAGNOSTIC LABORATORIES 49

8.4 OTHERS 49

9 GLOBAL HBA1C TESTING MARKET, BY REGION
9.1 OVERVIEW 50

9.2 AMERICAS 52

9.2.1 OVERVIEW 52

9.2.2 NORTH AMERICA 55

9.2.3 LATIN AMERICA 62

9.3 EUROPE 64

9.3.1 OVERVIEW 64

9.3.2 WESTERN EUROPE 67

9.3.3 EASTERN EUROPE 82

9.4 ASIA-PACIFIC 84

9.4.1 OVERVIEW 84

9.4.2 CHINA 87

9.4.3 INDIA 89

9.4.4 JAPAN 91

9.4.5 SOUTH KOREA 93

9.4.6 AUSTRALIA 95

9.4.7 REST OF ASIA-PACIFIC 97

9.5 MIDDLE EAST & AFRICA 99

9.5.1 OVERVIEW 99

9.5.2 MIDDLE EAST 102

9.5.3 AFRICA 104

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 106

10.2 COMPANY SHARE ANALYSIS, 2018 (%) 106

11 COMPANY PROFILES
11.1 ABBOTT LABORATORIES 108

11.1.1 COMPANY OVERVIEW 108

11.1.2 FINANCIAL OVERVIEW 108

11.1.3 PRODUCTS/SERVICES OFFERED 109

11.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109

11.1.5 SWOT ANALYSIS 109

11.1.6 KEY STRATEGIES 110

11.2 BIO-RAD LABORATORIES, INC. 111

11.2.1 COMPANY OVERVIEW 111

11.2.2 FINANCIAL OVERVIEW 111

11.2.3 PRODUCTS/SERVICES OFFERED 112

11.2.4 KEY DEVELOPMENTS 112

11.2.5 SWOT ANALYSIS 113

11.2.6 KEY STRATEGIES 113

11.3 DANAHER CORPORATION 114

11.3.1 COMPANY OVERVIEW 114

11.3.2 FINANCIAL OVERVIEW 114

11.3.3 PRODUCTS/SERVICES OFFERED 115

11.3.4 KEY DEVELOPMENTS 115

11.3.5 SWOT ANALYSIS 115

11.3.6 KEY STRATEGIES 115

11.4 F. HOFFMANN-LA ROCHE LTD 116

11.4.1 COMPANY OVERVIEW 116

11.4.2 FINANCIAL OVERVIEW 116

11.4.3 PRODUCTS/SERVICES OFFERED 117

11.4.4 KEY DEVELOPMENTS 117

11.4.5 SWOT ANALYSIS 117

11.4.6 KEY STRATEGIES 118

11.5 SIEMENS HEALTHINEERS 119

11.5.1 COMPANY OVERVIEW 119

11.5.2 FINANCIAL OVERVIEW 119

11.5.3 PRODUCTS/SERVICES OFFERED 120

11.5.4 KEY DEVELOPMENTS 120

11.5.5 SWOT ANALYSIS 120

11.5.6 KEY STRATEGIES 121

11.6 EKF DIAGNOSTICS 122

11.6.1 COMPANY OVERVIEW 122

11.6.2 FINANCIAL OVERVIEW 122

11.6.3 PRODUCTS/SERVICES OFFERED 123

11.6.4 KEY DEVELOPMENTS 123

11.6.5 SWOT ANALYSIS 123

11.6.6 KEY STRATEGIES 124



11.7 ARKRAY, INC. 125

11.7.1 COMPANY OVERVIEW 125

11.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW 125

11.7.3 PRODUCTS/SERVICES OFFERED 125

11.7.4 KEY DEVELOPMENTS 125

11.7.5 SWOT ANALYSIS 126

11.7.6 KEY STRATEGIES 126

11.8 TRINITY BIOTECH PLC. 127

11.8.1 COMPANY OVERVIEW 127

11.8.2 FINANCIAL OVERVIEW 127

11.8.3 PRODUCTS/SERVICES OFFERED 128

11.8.4 KEY DEVELOPMENTS 128

11.8.5 SWOT ANALYSIS 128

11.8.6 KEY STRATEGIES 128

11.9 PTS DIAGNOSTICS 129

11.9.1 COMPANY OVERVIEW 129

11.9.2 FINANCIAL OVERVIEW 129

11.9.3 PRODUCTS/SERVICES OFFERED 129

11.9.4 KEY DEVELOPMENTS 129

11.9.5 SWOT ANALYSIS 130

11.9.6 KEY STRATEGIES 130

11.10 DIASYS DIAGNOSTIC SYSTEMS GMBH 131

11.10.1 COMPANY OVERVIEW 131

11.10.2 FINANCIAL OVERVIEW 131

11.10.3 PRODUCTS/SERVICES OFFERED 131

11.10.4 KEY DEVELOPMENTS 131

11.10.5 SWOT ANALYSIS 132

11.10.6 KEY STRATEGIES 132

12 APPENDIX
12.1 REFERENCES 133

12.2 RELATED REPORTS 133



 


List Of Tables


TABLE 1 LIST OF ASSUMPTIONS 20

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24

TABLE 3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 39

TABLE 4 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2016–2025 (USD MILLION) 40

TABLE 5 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 40

TABLE 6 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2016–2025 (USD MILLION) 41

TABLE 7 GLOBAL HBA1C TESTING MARKET FOR BENCH-TOP DEVICE, BY REGION, 2016–2025 (USD MILLION) 41

TABLE 8 GLOBAL HBA1C TESTING MARKET FOR HANDHELD DEVICE, BY REGION, 2016–2025 (USD MILLION) 42

TABLE 9 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 44

TABLE 10 GLOBAL HBA1C TESTING MARKET FOR ION-EXCHANGE HPLC, BY REGION, 2016–2025 (USD MILLION) 45

TABLE 11 GLOBAL HBA1C TESTING MARKET FOR ENZYMATIC ASSAY, BY REGION, 2016–2025 (USD MILLION) 45

TABLE 12 GLOBAL HBA1C TESTING MARKET FOR TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA), BY REGION,

2016–2025 (USD MILLION) 46

TABLE 13 GLOBAL HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 48

TABLE 14 GLOBAL HBA1C TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2016–2025 (USD MILLION) 48

TABLE 15 GLOBAL HBA1C TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016–2025 (USD MILLION) 49

TABLE 16 GLOBAL HBA1C TESTING MARKET, BY REGION, 2016–2025 (USD MILLION) 51

TABLE 17 AMERICAS: HBA1C TESTING MARKET, BY REGION, 2016–2025 (USD MILLION) 53

TABLE 18 AMERICAS: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 53

TABLE 19 AMERICAS: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 53

TABLE 20 AMERICAS: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 54

TABLE 21 AMERICAS: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 54

TABLE 22 NORTH AMERICA: HBA1C TESTING MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 55

TABLE 23 NORTH AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 56

TABLE 24 NORTH AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 56

TABLE 25 NORTH AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 57

TABLE 26 NORTH AMERICA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 57

TABLE 27 US: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 58

TABLE 28 US: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 58

TABLE 29 US: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 59

TABLE 30 US: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 59

TABLE 31 CANADA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 60

TABLE 32 CANADA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 60

TABLE 33 CANADA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 61

TABLE 34 CANADA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 61

TABLE 35 LATIN AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 62

TABLE 36 LATIN AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 62

TABLE 37 LATIN AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 63

TABLE 38 LATIN AMERICA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 63

TABLE 39 EUROPE: HBA1C TESTING MARKET, BY REGION, 2016–2025 (USD MILLION) 64

TABLE 40 EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 65

TABLE 41 EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 65

TABLE 42 EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 66

TABLE 43 EUROPE: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 66

TABLE 44 WESTERN EUROPE: HBA1C TESTING MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 67

TABLE 45 WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 68

TABLE 46 WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 68

TABLE 47 WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 69

TABLE 48 WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 69

TABLE 49 UK: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 70

TABLE 50 UK: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 70

TABLE 51 UK: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 71

TABLE 52 UK: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 71

TABLE 53 GERMANY: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 72

TABLE 54 GERMANY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 72

TABLE 55 GERMANY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 73

TABLE 56 GERMANY: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 73

TABLE 57 FRANCE: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 74

TABLE 58 FRANCE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 74

TABLE 59 FRANCE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 75

TABLE 60 FRANCE: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 75

TABLE 61 ITALY: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 76

TABLE 62 ITALY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 76

TABLE 63 ITALY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 77

TABLE 64 ITALY: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 77

TABLE 65 SPAIN: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 78

TABLE 66 SPAIN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 78

TABLE 67 SPAIN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 79

TABLE 68 SPAIN: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 79

TABLE 69 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 80

TABLE 70 REST OF WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 80

TABLE 71 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 81

TABLE 72 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 81

TABLE 73 EASTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 82

TABLE 74 EASTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 82

TABLE 75 EASTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 83

TABLE 76 EASTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 83

TABLE 77 ASIA-PACIFIC: HBA1C TESTING MARKET, BY COUNTRY,2016–2025 (USD MILLION) 84

TABLE 78 ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 85

TABLE 79 ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 85

TABLE 80 ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 86

TABLE 81 ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 86

TABLE 82 CHINA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 87

TABLE 83 CHINA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 87

TABLE 84 CHINA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 88

TABLE 85 CHINA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 88

TABLE 86 INDIA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 89

TABLE 87 INDIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 89

TABLE 88 INDIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 90

TABLE 89 INDIA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 90

TABLE 90 JAPAN: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 91

TABLE 91 JAPAN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 91

TABLE 92 JAPAN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 92

TABLE 93 JAPAN: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 92

TABLE 94 SOUTH KOREA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 93

TABLE 95 SOUTH KOREA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 93

TABLE 96 SOUTH KOREA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 94

TABLE 97 SOUTH KOREA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 94

TABLE 98 AUSTRALIA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 95

TABLE 99 AUSTRALIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 95

TABLE 100 AUSTRALIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 96

TABLE 101 AUSTRALIA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 96

TABLE 102 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 97

TABLE 103 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 97

TABLE 104 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 98

TABLE 105 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 98

TABLE 106 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY REGION,2016–2025 (USD MILLION) 99

TABLE 107 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 100

TABLE 108 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 100

TABLE 109 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 101

TABLE 110 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 101

TABLE 111 MIDDLE EAST: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 102

TABLE 112 MIDDLE EAST: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 102

TABLE 113 MIDDLE EAST: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 103

TABLE 114 MIDDLE EAST: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 103

TABLE 115 AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2016–2025 (USD MILLION) 104

TABLE 116 AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2016–2025 (USD MILLION) 104

TABLE 117 AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2016–2025 (USD MILLION) 105

TABLE 118 AFRICA: HBA1C TESTING MARKET, BY END USER, 2016–2025 (USD MILLION) 105

TABLE 119 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 109

TABLE 120 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109

TABLE 121 BIO-RAD LABORATORIES INC.: PRODUCTS/SERVICES OFFERED 112

TABLE 122 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 112

TABLE 123 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 115

TABLE 124 DANAHER CORPORATION: KEY DEVELOPMENTS 115

TABLE 125 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 117

TABLE 126 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 117

TABLE 127 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED 120

TABLE 128 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 120

TABLE 129 EKF DIAGNOSTICS PRODUCTS/SERVICES OFFERED 123

TABLE 130 EKF DIAGNOSTICS KEY DEVELOPMENTS 123

TABLE 131 ARKRAY, INC.: PRODUCTS/SERVICES OFFERED 125

TABLE 132 ARKRAY, INC.: KEY DEVELOPMENTS 125

TABLE 133 TRINITY BIOTECH PLC.: PRODUCTS/SERVICES OFFERED 128

TABLE 134 PTS DIAGNOSTICS: PRODUCTS/SERVICES OFFERED 129

TABLE 135 DIASYS DIAGNOSTIC SYSTEMS GMBH: PRODUCTS/SERVICES OFFERED 131
 


List Of Figures


FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2018) 15

FIGURE 3 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY PRODUCT 16

FIGURE 4 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY TECHNOLOGY 17

FIGURE 5 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY END USER 18

FIGURE 6 GLOBAL HBA1C TESTING MARKET: STRUCTURE 20

FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 26

FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 29

FIGURE 9 DRIVERS IMPACT ANALYSIS 31

FIGURE 10 RESTRAINT IMPACT ANALYSIS 32

FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HBA1C TESTING MARKET 34

FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 36

FIGURE 13 GLOBAL HBA1C TESTING MARKET SHARE, BY PRODUCT, 2018 (%) 38

FIGURE 14 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2018 & 2025 (USD MILLION) 38

FIGURE 15 GLOBAL HBA1C TESTING MARKET SHARE, BY TECHNOLOGY, 2018 (%) 43

FIGURE 16 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2018 & 2025 (USD MILLION) 43

FIGURE 17 GLOBAL HBA1C TESTING MARKET SHARE, BY END USER, 2018 (%) 47

FIGURE 18 GLOBAL HBA1C TESTING MARKET, BY END USER, 2018 & 2025 (USD MILLION) 47

FIGURE 19 GLOBAL HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%) 50

FIGURE 20 GLOBAL HBA1C TESTING MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 50

FIGURE 21 AMERICAS: HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%) 52

FIGURE 22 NORTH AMERICA: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2018 (%) 55

FIGURE 23 EUROPE: HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%) 64

FIGURE 24 WESTERN EUROPE: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2018 (%) 67

FIGURE 25 ASIA-PACIFIC: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2018 (%) 84

FIGURE 26 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET SHARE, BY REGION, 2018 (%) 99

FIGURE 27 GLOBAL HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2018 (%) 106

FIGURE 28 INDIA HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2018 (%) 107

FIGURE 29 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 108

FIGURE 30 ABBOTT LABORATORIES: SWOT ANALYSIS 109

FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 111

FIGURE 32 BIO-RAD LABORATORIES INC: SWOT ANALYSIS 113

FIGURE 33 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 114

FIGURE 34 DANAHER CORPORATION: SWOT ANALYSIS 115

FIGURE 35 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 116

FIGURE 36 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 117

FIGURE 37 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 119

FIGURE 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS 120

FIGURE 39 EKF DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT 122

FIGURE 40 EKF DIAGNOSTICS: SWOT ANALYSIS 123

FIGURE 41 ARKRAY, INC.: SWOT ANALYSIS 126

FIGURE 42 TRINITY BIOTECH PLC.: FINANCIAL OVERVIEW SNAPSHOT 127

FIGURE 43 TRINITY BIOTECH PLC.: SWOT ANALYSIS 128

FIGURE 44 PTS DIAGNOSTICS: SWOT ANALYSIS 130

FIGURE 45 DIASYS DIAGNOSTIC SYSTEMS GMBH: SWOT ANALYSIS 132
 


2020 Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

This new 68-country report is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and

USD 45000 View Report

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

Europe HbA1c Testing Device Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe HbA1c Testing Device market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

Global HbA1c Testing Device Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of HbA1c Testing Device is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available